Given 20-HETE vasoconstrictive and pro-inflammatory bioactions, 20-HETE and GPR75 may play a significant role in the pathogenesis of portal hypertension observed during cirrhosis, portal vein thromboses (PVT), and splanchnic thromboses. The gene discussed is GPR75; the disease is portal hypertension.